Event-Driven Stocks

MYMETICS CORP

Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕

Signs● 1 good● 2 warning● 2 severedetails ↓

Financials

SEC XBRL · annual
 FY21FY20
Revenue——
Operating income——
Net income−$4.7M−$4.2M
Total assets$7.6M$8.1M
Total liabilities$67.7M$63.4M
Equity−$60.1M−$55.4M
EPS (diluted)$-0.02$-0.01
Shares out.303.8M303.8M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2021
Operating margin
—
Net margin
—
Return on equity
7.9%
Return on assets
−62.0%
Return on capital (ROCE)
—
Liabilities / assets
887.3%
Debt / equity
—
Book value / share
$-0.20
Revenue growth (YoY)
—
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2021
Accruals / assets
−39.7%clean
Piotroski F-Score
2/7weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
46
/ 100
Profitability 50Growth n/aCatalyst 67Earnings quality 67Financial strength 0

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 2 severe● 2 warning● 1 good
  • Negative shareholder equity
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • High leverage (liabilities > 70% of assets)
  • Negative operating cash flow
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

Insider transactions

SEC Form 4 · most recent
8 acquisitions1 disposals1 open-market buy(s)net +13.7M shares · last 9
InsiderDateTypeSharesPrice
Kempers Ronald Hugo GerardOfficer — President, CEO, CFODec 27, 2013Option exercise3.0M$0.02
Martin Jacques FrancoisOfficer — CEOJul 8, 2010Sell150,000$0.20
Rochet ChristianDirectorJul 20, 2009Sell1.9M$0.17
Stern Ernest MDirectorJun 23, 2008Grant500,000—
Stern Ernest MDirectorMar 17, 2008Grant500,000—
Rochet ChristianOfficer — CEO, PresidentJun 5, 2007Buy6.0M—
Luebke ErnstOfficer — Chief Financial OfficerJun 18, 2007Grant2.5M—
Khd Humboldt Wedag International Ltd.10% ownerMay 10, 2005J2.5M$0.00
Khd Humboldt Wedag International Ltd.10% ownerMay 10, 2005J500,000—

Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (2)